Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

ASCO Resets Stage For Third-Generation EGFR Contest: May Come Down To Safety Or Resistance

Executive Summary

To some market observers, latest round of data for new EGFR inhibitors presented at the ASCO meeting gives AstraZeneca an edge on efficacy over close competitor Clovis, but differences in trial designs make it hard to compare efficacy at this time.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register